January 4, 2021 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Mass Spectrometry

Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures

MBT Sepsityper Kit US IVD enables rapid, specific detection of many cases of bacteremia-induced sepsis to assist infectious disease specialists in potentially life-saving decisions Used for MALDI Biotyper® (MBT) identification directly from Positive Blood Cultures (PBC) with short time-to-result (TTR) of less than 30 minutes US FDA clearance received in late December for diagnostic use... Read more

December 28, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Quanterix Receives FDA Emergency Use Authorization for Semi-quantitative Antibody Test

Infectious Disease Technology Antibody test available on Simoa HD-X Analyzer® detects and quantitates IgG antibodies to SARS-CoV-2 in serum or EDTA plasma   BILLERICA, Mass., December 28, 2020 – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Administration (FDA) has issued an Emergency Use... Read more

December 21, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Release of Fully-Automatic PCR Testing System for Clinics Contributes to Japan’s COVID-19 Testing Capabilities

Shimadzu Corporation has released the AutoAmp Genetic Analyzer (“AutoAmp”) for sale in Japan, enabling clinics to perform fully-automatic PCR testing. With the AutoAmp, classified as a Class I medical device, PCR testing involves simply setting the biological samples, dispensing tips, reagent vials, and reaction vessels in place. This instrument can also be used to detect... Read more

December 16, 2020 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics Product Launch

EUROIMMUN Launches Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected Patients

Automatable and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virus WALTHAM, Mass. – December 16, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein. The assay adds to the Company’s broad product... Read more

December 15, 2020 Clinical Research/Diagn. Life Science Tools PR/Corporate

Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors

December 15, 2020 SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research... Read more

December 15, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service

Tue 15th December 2020 Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next generation DNA/RNA sequencing technology company and SourceBio International plc (“SourceBio”), an international provider of integrated state of the art laboratory services and products, announce a strategic commercial... Read more

December 15, 2020 Clinical Research/Diagn. Lab Top-10 Other Lab Products/Services

Thermo Fisher Scientific Expands Clinical Supply Chain Services in Europe

Clinical supply and specialized cold chain storage sites in Germany support growing demand for expanded services WALTHAM, Mass., Dec. 15, 2020 /PRNewswire/ — To meet accelerating demand for robust clinical supply chain services throughout Europe, Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein, Germany.... Read more

December 14, 2020 Clinical Research/Diagn. Lab Top-10 Life Science Tools PAI Top-10 PR/Corporate Product Launch

EUROIMMUN Receives CE Mark for New PCR Test to Differentiate Between COVID-19 and Flu

Company expands testing portfolio for acute diagnostics of COVID-19 WALTHAM, Mass. – December 14, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus type B. It expands the testing portfolio for acute COVID-19 diagnostics... Read more

December 10, 2020 Bio/Pharma/CRO Clinical Research/Diagn.

Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020

People with muscle-invasive urothelial cancer (MIUC) who had detectable circulating tumour DNA (ctDNA) were more likely to benefit from treatment with adjuvant (after surgery) Tecentriq monotherapy, compared with those without ctDNA The goal of current treatment in people with MIUC is to provide early intervention to reduce the risk of the disease recurring or spreading... Read more